Cargando…

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum

Malaria is a deadly disease responsible for between 550,000 and 627,000 deaths annually. There is a pressing need to develop vaccines focused on malaria elimination. The complex lifecycle of Plasmodium falciparum provides opportunities not only to target the infectious sporozoite stage, introduced b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Clifford T. H., Cao, Yi, Clark, Leor C., Tripathi, Abhai K., Zavala, Fidel, Dwivedi, Garima, Knox, James, Alameh, Mohamad-Gabriel, Lin, Paulo J. C., Tam, Ying K., Weissman, Drew, Kumar, Nirbhay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715627/ https://www.ncbi.nlm.nih.gov/pubmed/36456563 http://dx.doi.org/10.1038/s41541-022-00577-8

Ejemplares similares

Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
por: Hayashi, Clifford T. H., et al.
Publicado: (2023)

Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
por: Mallory, Katherine L., et al.
Publicado: (2021)

Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection
por: Martin, Gregory M., et al.
Publicado: (2023)

Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9
por: Martin, Gregory M., et al.
Publicado: (2023)

Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
por: Scally, Stephen W., et al.
Publicado: (2018)

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023)

Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
por: KC, Natasha, et al.
Publicado: (2022)

Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP)
por: Parums, Dinah V.
Publicado: (2021)

Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023)

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission
por: Cao, Yi, et al.
Publicado: (2022)

Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
por: Connors, Jennifer, et al.
Publicado: (2022)

Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
por: Connors, Jennifer, et al.
Publicado: (2023)

Inhibition of PQS signaling by the Pf bacteriophage protein PfsE enhances viral replication in Pseudomonas aeruginosa
por: Schwartzkopf, Caleb M., et al.
Publicado: (2023)

Humoral Immune Responses to P. falciparum Circumsporozoite Protein (Pfcsp) Induced by the RTS, S Vaccine – Current Update
por: Ngulube, Peter
Publicado: (2023)

The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo
por: Flores-Garcia, Yevel, et al.
Publicado: (2021)

2342. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
por: England, Ross N, et al.
Publicado: (2023)

Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
por: Singh, Susheel K., et al.
Publicado: (2019)

Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins
por: Singh, Kavita, et al.
Publicado: (2020)

Chromobacterium Csp_P Reduces Malaria and Dengue Infection in Vector Mosquitoes and Has Entomopathogenic and In Vitro Anti-pathogen Activities
por: Ramirez, Jose Luis, et al.
Publicado: (2014)

ReverCSP: Time-Travelling in CSP Computations
por: Galindo, Carlos, et al.
Publicado: (2020)

Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine
por: Singh, Susheel K., et al.
Publicado: (2021)

Nanobodies against Pfs230 block Plasmodium falciparum transmission
por: Dietrich, Melanie H., et al.
Publicado: (2022)

Role of Pfs47 in the dispersal of ancestral Plasmodium falciparum malaria through adaptation to different anopheline vectors
por: Molina-Cruz, Alvaro, et al.
Publicado: (2023)

Robust antibody and CD8(+) T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection
por: Espinosa, Diego A., et al.
Publicado: (2017)

Techno-Economic Optimization of CSP Plants with Free-Falling Particle Receivers
por: González-Portillo, Luis F., et al.
Publicado: (2021)

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum
por: Beutler, Nathan, et al.
Publicado: (2022)

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1
por: Egan, Kevin P., et al.
Publicado: (2023)

Hybrid LNP Prime Dendritic Cells for Nucleotide Delivery
por: Das, Riddha, et al.
Publicado: (2023)

Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission
por: Rausch, Kelly M., et al.
Publicado: (2023)

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
por: Huang, Wei-Chiao, et al.
Publicado: (2020)

Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice
por: Healy, Sara A., et al.
Publicado: (2021)

Rare Alleles and Signatures of Selection on the Immunodominant Domains of Pfs230 and Pfs48/45 in Malaria Parasites From Western Kenya
por: Ochwedo, Kevin O., et al.
Publicado: (2022)

Purification and initial characterization of Plasmodium falciparum K(+) channels, PfKch1 and PfKch2 produced in Saccharomyces cerevisiae
por: Molbaek, Karen, et al.
Publicado: (2020)

The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania
por: Bousema, Teun, et al.
Publicado: (2010)

Photoexcited Enzymes for Asymmetric Csp (3)−Csp (3) Cross‐Electrophile Couplings
por: Schmidt, Sandy
Publicado: (2022)

A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli
por: Chowdhury, Debabani Roy, et al.
Publicado: (2009)

The effects of PEGylation on LNP based mRNA delivery to the eye
por: Ryals, Renee C., et al.
Publicado: (2020)

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
por: Moghimi, S. Moein
Publicado: (2021)

Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
por: Ghattas, Majed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvj545rothns18ttl47j0sfotf